Last week's biggest management and board changes: Kohl's, Biogen, adidas

By Sarina Isaacs and Senad Karaahmetovic

Investing.com - Here are the biggest management and board changes from the past week, as first reported on InvestingPro+.

Keurig Dr Pepper (NASDAQ:KDP) announced the resignation of Ozan Dokmecioglu as Chief Executive Officer and a member of the KDP Board of Directors. Bob Gamgort, the Company's current Executive Chairman and former CEO, was reappointed by the Board to the role of CEO, in addition to continuing as Chairman.

Bed Bath & Beyond Inc (NASDAQ:BBBY) announced the appointment of Bart Sichel as EVP, Chief Marketing & Customer Officer. Mr. Sichel will oversee fully integrated marketing and customer strategies for Bed Bath & Beyond, buybuy BABY and Harmon, reporting directly to Bed Bath & Beyond Inc. President and CEO, Sue Gove. "Bart has an excellent track record when it comes to building brands, driving brand loyalty, marketing strategy, advertising, and customer insights and analytics," said Gove.

Biogen Inc (NASDAQ:BIIB) announced that its Board of Directors has appointed Christopher A. Viehbacher as President and Chief Executive Officer and a member of the Board of Directors, effective November 14. Viehbacher succeeds Michel Vounatsos, who has led the company since 2017. According to the company, Viehbacher has extensive international experience in both large pharmaceutical companies and entrepreneurial biotech companies.

Kohl's Corp (NYSE:KSS) announced that its CEO Michelle Gass plans to step down as CEO and member of the Kohl’s Board of Directors starting from December 2, 2022. Tom Kingsbury will serve as interim CEO until a permanent successor is named. Kingsbury stated, “I’m proud and humbled to take the Interim CEO role during such an important time for the Company." Kohl's shares were down about 37% year-to-end based on Friday's close.

The Supervisory Board of Adidas AG (OTC:ADDYY) named Bjørn Gulden to be CEO and member of the Executive Board and CEO, effective January 1, 2023. He succeeds Kasper Rorsted, who agreed with the Supervisory Board that he will step down as CEO and leave the company upon expiry of November 11, 2022. Harm Ohlmeyer, Chief Financial Officer of adidas AG, will lead the company in the interim until December 31, 2022.

Manulife Financial Corp (NYSE:MFC) announced the appointment of Don Lindsay as Vice Chair of the Board of Directors of Manulife Financial Corporation and The Manufacturers Life Insurance Company. "John Cassaday will retire on February 15, 2023 after thirty years of distinguished service as a member of the Board, and as Chairman for the past five years, at which time Don will become Chair of the Board," said the company.

Seagen Inc (NASDAQ:SGEN) announced that its Board of Directors has appointed David R. Epstein as CEO and a member of the Board of Directors. "Mr. Epstein brings more than 30 years of experience in the biopharmaceutical industry, including more than 25 years at Novartis where he built its oncology business unit from initiation to second largest in the world and then served as CEO of Novartis Pharmaceuticals, a division of Novartis AG," said the company.